Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study by Paula A Monteiro et al.
Monteiro et al. BMC Research Notes 2013, 6:89
http://www.biomedcentral.com/1756-0500/6/89RESEARCH ARTICLE Open AccessMorphological and metabolic determinants of
nonalcoholic fatty liver disease in obese youth:
a pilot study
Paula A Monteiro1*, Jorge Mota2, Loreana S Silveira1, Suziane U Cayres3, Bárbara de Moura M Antunes4,
Romulo Araujo Fernandes3 and Ismael F Freitas Jr3Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) related to obesity has been rising in the last decades, though
the morphological and metabolic determinants are remain unclear in children. The aim of this study was to analyze
the morphological determinants and metabolic abnormalities in obese children and adolescents, classified either as
with (P-NAFLD) or without (N-NAFLD). The sample comprised 190 individuals, aged 6 to 16 years-old, assigned into
one of 4 groups according to sex and presence or absence of NAFLD. Obesity was obtained according to body
mass index (BMI) cut-points. Body composition variables was estimated by Dual-Energy X-ray Absorptiometry
(DEXA). Total cholesterol (TC), triglycerides (TG), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), insulin, fasting
glucose (FG) and blood pressure were also analyzed. The diagnosis of NAFLD, as well as the measurement of
intra-abdominal fat tissue thickness (IAF) and subcutaneous abdominal fat tissue thickness (SCF), was carried-out
by ultrasound.
Results: Males and females belonging to P-NAFLD group showed, respectively, higher TFM and IAF. When data
were adjusted for sex, age and total fat mass, those in P-NAFLD showed statistically higher IAF, TFM and TG.
Conclusion: Our study showed that obese youngsters who were assigned to P-NAFLD group were twice as likely
to present higher concentration of triglycerides, higher levels of trunk fat, as well as intra-abdominal fat compared
to their N-NAFLD counterparts even after adjustments for sex, age, pubertal stage and total body fat mass.
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Nonalcoholic fatty liver disease (NAFLD) or liver
steatosis is characterized by a pathological fat accumula-
tion in the liver, ranging from simple steatosis to non-
alcoholic steatohepatitis, advanced fibrosis, cirrhosis and
liver cancer [1].
Although the prevalence of NAFLD is not well known,
it is the most common form of pediatric liver disease
[2]. Fat accumulation in the liver, mainly in the triglycer-
ides form, can range from5 to 10% of the liver weight
[2,3] and studies have shown a strong association be-
tween obesity and NAFLD [4]. With increasing obesity* Correspondence: paulinha__1003@hotmail.com
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reproduction in any medium, provided the orrates globally, NAFLD is considered a growing public
health concern [5]. The pathogenesis of NAFLD is com-
plex and comprises multiple factors such as genetic
predisposition, life style, visceral adiposity, insulin resist-
ance, ethnicity, age and sex [6,7]. Some studies indicate
that the histopathological signs of steatosis can appear
between 11 and 13 years, for both sexes. This timing
suggests that puberty may play an important role inthe
development of this pathology [8] due to the increased
production of sex hormones and insulin resistance,
which might be crucial to NAFLD genesis [9].
Although obese individuals are more prone to present
NAFLD, data regarding the differences in clinical mani-
festation and related metabolic abnormalities in those
with and without NAFLD diagnosis is scarce. To the
best of our knowledge there is only one study in Brazilal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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body composition and metabolic profile in young obese
with NAFLD diagnosis in post-apex pubertal stage [4].
However, the data were not analyzed according to mat-
urational stage and did not indicate whether or not fat
distribution and cardio-metabolic profile are associated
NAFLD. To fill this gap in the literature, our study
aimed to analyze the association between NAFLD and




Data of 190 obese children and adolescents, aged 6 to 16
years old, were collected during the second semester of
2010. The participants were invited, through media ad-
vertisement, to participate in a community-based pro-
gram. This program aimed to treat obesity focused on
enhancing exercise and nutritional orientation and was
carried out at facilities of the Universidade Estadual
Paulista - Campus of Presidente Prudente (FCT/
UNESP), São Paulo, Brazil.
The inclusion criteria were: (a) to be classified as obese
according to the reference values proposed by Cole et al.
[10], (b) aged between 6 and 16 years at the first evalu-
ation date, and (c) participants and parents/guardians
signed a written informed consent form for the partici-
pation in the program.
The Ethical Committee of FCT/UNESP approved this
study (Protocol number 07/2009).
Anthropometry
Body weight (BW) was measured with an electronic
scale (precision 0.1 kg [Filizzola PL 150, Filizzola Ltda])
and the height (H) with a wall-mounted stadiometer
(precision 0.1 cm [SannyW, São Paulo, Brazil]). Both
measurements were carried out with participants wear-
ing light clothing and no shoes. Body mass index (BMI)
was then calculated as kg/m2. All anthropometric mea-
surements were performed by trained researchers,
according to standardized techniques [11].
Dual Energy X-Ray Absorptiometry
Body composition was estimated by a Dual-energy X-ray
absorptiometry (DEXA) scanner (Lunar DPX-NT; Gen-
eral Electric Healthcare, Little Chalfont, Buckingham-
shire), with software version 4.7. The method estimated
the body composition by fractionating the body into
three anatomical compartments: fat-free mass (FFM), fat
mass (FM) and bone mineral content. The assessment
was carried out in approximately 15 minutes, and the
subjects remained still and in a supine position through-
out the scan, wearing light clothing while lying flat on
their back with arms by the side. The results wereexpressed in kilograms of FFM and FM. The absolute
(kg) and relative (%) values from trunk fat (%TF) were
also assessed by DEXA. All DEXA measurements were
carried-out at the University laboratory in a controlled
temperature room. Each morning, before the beginning
of the measurements, the DEXA was calibrated by the
same researcher, according to the references provided by
the manufacturer.
Stages of puberty
The stage of puberty was self-assessed by the partici-
pants aged older than 10 years. A standardized series of
drawings was given to the subjects to assess their own
pubertal development. Girls received drawings of the five
stages of Tanner breast and female pubic hair develop-
ment with appropriate descriptions accompanying the
drawings. Boys were given line drawings of boys showing
the five Tanner stages of pubic hair development, with
appropriate written descriptions. Participants were asked
to select the drawing of the stage that best indicated his
other own development. All procedures were done as
described by Marshall & Tanner [12]. The results were
placed by each subject in a locked box with only their
subject id as an identifier, so as to guarantee the integrity
and anonymity of the subjects. Only the main researcher
had access to those questionnaires.
The breast stages for girls and genitalia stages for boys
were chosen to classify the sexual maturation status be-
cause they are recommended by a World Health
Organization Expert Committee as indicators of sexual
maturation for international use [13]. The original five
pubertal stages were grouped in three new groups: par-
ticipants aged under 10 years and those who answered
stage 1, were grouped in group 1; those who answered
stages 2 and 3, were grouped in group 2; and those who
answered stages 4 and 5, were grouped in group 3.
Ultrasound
The ultrasound equipment (Toshiba Aplio Model
Tochigi-ken, Japan) was used by a trained radiologist to
assess the level of fat accumulation and the morphology
of the liver. Finally the NAFLD diagnosis was made by a
hepatologist. The NAFLD was graded semi qualitatively
as described by Shannon [14]: Score 0 is absence of
steatosis, defined as normal liver echo texture; Score 1 is
mild steatosis, defined as slight and diffuse increase in
fine parenchymal echoes, normal visualization of dia-
phragm and portal vein borders; Score 2 is moderate
steatosis, defined as a diffuse increase in fine echoes with
slightly impaired visualization of diaphragm and portal
vein borders and; Score 3 is severe steatosis, defined as
fine echoes with poor or no visualization of diaphragm,
portal vein borders and posterior portion of the right
lobe. The participants were labeled as “without NAFLD”
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grade of fatty infiltration in the liver were labeled as
“with NAFLD” (P-NAFLD).
The ultrasound is an image evaluation that provides
diagnosis of NAFLD and measures, in centimeters,
the length of intra-abdominal fat (IAF) and subcutane-
ous fat (SCF).
Blood samples
A 12-hour fasting blood sample collection was taken
and analyzed by a private laboratory located in the city
of Presidente Prudente, Brazil. Samples were collected in
vacuum tubes containing gel with anticoagulant. Then
the blood was centrifuged for 10 minutes at 3,000 rpm.
To measure total cholesterol (TC), triglyceride (TG),
HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C)
and glucose (GL), an enzymatic colorimetric kit
processed in a unit Autohumalyzer A5 was used [15]. In-
sulin was analyzed using the RayBioW Human Insulin
ELISA Kit, following the Manual Revised Nov 23, 2009.
Blood pressure
An automated digital blood pressure monitor (Omron
Healthcare, Inc., Intellisense, modelo HEM 742 INT,Table 1 General characteristics and comparison of morpholog
adolescents with and without nonalcoholic fatty liver disease
Male N-NAFLD Male P-NAFLD
Mean (SD) Mean (SD)
Age (years) 10.8(2.6) 121(2.5)
Weight (kg) 67.8(20.4)ab 78.9(22.4)a
Height (cm) 151.1(13.8) 155.8(13.1)
BMI (kg/m2) 29.0(4.7)a 31.8(4.9)b
GL (mg/dl) 82.2(5.8) 82.7(6.2)
TG (mg/dl) 113.9(49.4) 138.8(78.7)
TC (mg/dl) 167.0(35.5) 168.3(33.2)
HDL-C (mg/dl) 43.4(10.3) 40.9(11.3)
LDL-C (mg/dl) 100.7(31.8) 99.5(32.7)
SCF (cm) 3.0(1.2) 3.4(1.1)
IAF (cm) 4.6(1.5)a 5.2(2.0)a
%TF 44.3(5.9) 45.2(4.9)
FM (Kg) 30.1(10.8)ab 35.3(11.9)a
FFM (kg) 34.8(9.9)ab 40.1(11.5)a
TFM (kg) 13.5(5.2)a 17.0(5.9)b
SBP (mmHg) 119.0(14.2)ab 124.3(13.6)a
DBP (mmHg) 70.0(7.8) 72.4(8.9)
Insulin (μUI/mL) 61.6(51.4) 56.2(59.8)
N-NAFLD absence of nonalcoholic fatty liver disease; P-NAFLD presence of nonalco
glucose; TG = triglycerides; TC = total cholesterol; HDL-C = high density lipoprotein
abdominal fat tissue thickness; IAF = Intra-abdominal fat tissue thickness; %TF = Pe
SBP= systolic blood pressure; DBP= diastolic blood pressure; p<0.005; superscript leBannockburn, Illinois, USA) was used for the measure-
ment of systolic (SBP) and diastolic (DBP) blood pres-
sure. This equipment was previously validated for
pediatric population [16]. After fifteen minutes of resting
in a lying-down position, two measures were taken on
the right arm, with a two minute interval between them.
The mean value was used for statistical analysis.
Diagnosis of metabolic syndrome
For diagnosis of Metabolic Syndrome (MS), we adopted
the cut-point proposed by the World Health Organization
(WHO) [17] for adolescents. The MS was diagnosed in
subjects who presented three or more of the following risk
factors: Obesity (BMI > percentile 95 according Must
[17]); Glucose Homeostasis (prepubertal hyperinsulinemia
>15 mU/L; [18] [stage 1 Tanner] pubertal>30 mU/L [19];
[stages 2–4 Tanner] pospubertal ≥20 mU/L [stage 5 Tan-
ner]; Fasting Glucose ≥6.1mM/L and Impaired Glucose
Tolerance: 120min ≥ 7.8mM/L), Elevated Blood Pressure
(SBP > perc95 for age, sex and height proposed by
NHBPEP [19]). Dyslipidemia (Triglycerides >105mg/dL
for children< 10 years and >136mg/dL for children ≥ 10
years, HDL-C <35 mg/dL and Total Cholesterol > per-
centile 95).ical and metabolic syndrome components of obese
Female N-NAFLD Female P-NAFLD



















holic fatty liver disease; SD= standard deviation; BMI= Body Mass Index; GL =
-cholesterol; LDL-C = low density lipoprotein-cholesterol; SCF = Subcutaneous
rcentage of trunk fat; FM= Fat mass; FFM= Fat-free mass; TFM= Trunk fat mass;
tter means statistical difference between groups.
Table 2 Comparisons of body composition and metabolic
syndrome components of obese adolescents with
(presence) and without (absence) nonalcoholic fatty liver
disease, adjusted by sex, age, pubertal stage and total
body fat mass
Mean (SE) CI f p
TFM (kg) Presence 13.5(0.1) 13.3 13.8 11.49 0.001
Absence 14.5(0.2) 14.0 151
SCF (cm) Presence 3.1(0.0) 3.0 3.2 0.20 0.648
Absence 3.0(0.1) 2.8 3.3
IAF (cm) Presence 4.0(0.1) 3.8 4.3 10.03 0.002
Absence 4.8(0.2) 4.4 5.2
GL (mg/dl) Presence 81.7(0.5) 80.6 828 0.04 0.839
Absence 81.5(0.9) 795 83.5
TG (mg/dl) Presence 114.6(4.8) 105.0 1242 4.48 0.036
Absence 135.6(8.6) 118.6 152.6
TC (mg/dl) Presence 163.8(2.8) 158.2 169.3 0.00 0.983
Absence 164.0(4.9) 154.2 173.8
HDL-C (mg/dl) Presence 43.6(0.9) 41.8 45.4 2.12 0.147
Absence 40.8(1.6) 37.6 44.0
LDL-C (mg/dl) Presence 97.2(2.5) 92.1 102.3 0.07 0.792
Absence 95.9(4.5) 87.0 104.9
SBP (mmHg) Presence 118.2(1.0) 116.1 120.3 1.14 0.286
Absence 120.8(1.8) 117.1 124.4
DBP (mmHg) Presence 69.8(0.6) 68.5 71.2 1.51 0.220
Absence 71.6(1.2) 69.2 73.9
Insulin (μUI/mL) Presence 47.6(5.7) 36.2 59.0 1.62 0.205
Absence 62.4(10.2) 42.3 82.6
SE= Standard error; CI= Confidence Interval; p<0.005; TFM= trunk fat mass;
SCF= Subcutaneous abdominal fat tissue thickness; IAF= Intra-abdominal fat
tissue thickness; GL= glucose; TG= triglycerides; TC= total cholesterol; HDL-C=
high density lipoprotein; LDL-C= low density lipoprotein; SBP= systolic blood
pressure; DBP= diastolic blood pressure; 0= Absence of nonalcoholic Fat Liver
Disease; 1= Presence of nonalcoholic Fat Liver Disease.
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Descriptive data are shown as means and standard devi-
ation. One-way analysis of variance (ANOVA) was applied
to analyze the differences in body composition, blood pres-
sure and biochemical variables between males and females
within NAFLD groups. A multivariate analysis was used to
compare all variables within NAFLD group as dependent
variable. Data were adjusted for sex, age, pubertal stage
and total fat mass. The relative risk (odds ratio) and 95%
confidence interval were calculated by binary logistic re-
gression. The statistical significance was set at 5% for all
the analyses and the calculations were conducted using
SPSS, version 17.0 (SPSS Inc. Chicago. IL).
Results
Table 1 shows general characteristics and comparisons
of morphological and metabolic risk factors, according
to sex, as well aspresence and absence of NAFLD.
Among children and adolescents evaluated in this study,
18.7% (n = 35) had metabolic syndrome and 25.7%
(n = 48) had DGNAF. Of youth with DGNAF, 9.1%
(n = 17) also had syndrome metabolic. The comparisons
showed statistical differences in the BW (p=0.003), FM
(p=0.042), FFM (p<0.001) and SBP (p=0.039) between
males and females, respectively, with and without
NAFLD; BMI (p=0.001) between males with and without
NAFLD; FG (p<0.001) between females with and with-
out NAFLD, and in the TFM (p=0.002) between males
with and both sexes without NAFLD.
In Table 2 illustrates the multivariate analysis findings.
After adjustments for sex, age, pubertal stage and total
body fat mass, statistically significant differences were
observed in TG (p=0.036), TFM (p=0.001) and IAF
(P=0.002) for both NAFLD groups.
Table 3 shows the findings of regression analysis in
which only those variables that showed statistical signifi-
cance were incorporated into the model. Males of
P-NAFLD group were more likely to have higher levels
of %TF above median value (46.62%) while P-NAFLD
females were more likely to show IAF values above
median (3.75cm).
Discussion
The purpose of the present study was to analyze the
morphological determinants and metabolic abnormal-
ities in obese children and adolescents, classified
according to positive or negative diagnosis to NAFLD.
The main results of the present study are that gender
differences seem to be associated with NAFLD in obese
youth. Indeed, P-NAFLD males were more likely to have
higher levels of abdominal fat mass, while P-NAFLD fe-
males were more likely to show higher intra-abdominal
fat mass. Our data are noteworthy. Indeed, the relation-
ship between obesity and NAFLD in children was alsoobserved in a recent study [7]. Additionally, obese indi-
viduals are often afflicted with comorbidities caused by
obesity, such as NAFLD [20,21], that can evolve to more
damaging stages as cirrhosis and liver carcinoma [7].
In pediatric populations, previous studies have
reported that NAFLD is related to risk factors such as:
whole body and central obesity [6,22], insulin resistance
and type II diabetes [23]. Studies also suggest that chil-
dren who enter puberty with excessive fat and/or present
genetic basis are more likely to develop NAFLD [8,24].
Nonetheless, the amount of fat accumulated in the deep
abdominal region seems to be a key-factor in NAFLD
diagnosis. Furthermore, the profound endocrine, meta-
bolic and morphologic changes that occurred over time,
particularly in adolescence might explain the gender dif-
ferences found in the occurrence of NAFLD [25].
Table 3 Odds ratio of body composition and ultrasound analysis and of children and adolescents with and without
nonalcoholic fatty liver disease
Dependent variable: Nonalcoholic fatty liver disease
Male (Median) OR (OR95%CI) P
%TF (46.62%) Below 1 — —
Above 2.66 (1.06 – 6.69) 0.005
Female (median) OR (OR95%CI) P
IAF (3.75 cm) Below 1 — —
Above 3.09 (1.01 – 9.48) 0.048
OR= odds ratio; 95%CI= 95% confidence interval; %TF= percentage of trunck fat; LL= Left lobe of liver; IAF=Intra-abdominal fat tissue thickness; IAF+SCF=Intra-
abdominal plus Subcutaneous abdominal fat tissue thickness.
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stimulates accumulation of fat in the hip area and con-
tributes towards the cardiovascular risk events decrease
in women [26-28], as well as provides a protective effect
on the accumulation of fat in the liver, our results indi-
cate that a small increase in the amount of IAF in girls
is associated with P-NAFLD, independently of total fat
mass, sex, pubertal stage and age.
These findings are consistent with those obtained in
previous studies [29,30], suggesting that visceral adipos-
ity is the best variable for predicting the fat accumula-
tion in the liver, with a further possible explanation for
the differences between sex, being related to sex hor-
mones during puberty [28].
The discovery of the possible link between biological
mechanisms responsible for the changes in body fat dis-
tribution, in both males and females, from childhood to
adolescence, as well as the incidence of NAFLD, seems
to be a key factor deserving of further attention so as to
improve the prevention and treatment of NAFLD in
clinical and epidemiological settings.
Despite these important findings which indicate that
body fat in the trunk area is associated with NAFLD, es-
pecially in males, and that females seems to be more
sensitive to develop NAFLD with the same amount of
intra-abdominal fat them males. The main limitation of
the present study were the use of ultrasound as the only
method for diagnosis of NAFLD, without confirmation
by liver function enzymes.Conclusion
In conclusion, the higher concentration of trunk fat and
intra-abdominal fat, in obese adolescents may indicate po-
tential to elevate the risk of developing nonalcoholic fat
liver disease even when the results were adjusted for sex,
age, pubertal stage and total body fat mass. Further inves-
tigations are necessary to verify the possible link between
the mechanisms responsible for changes in hormonal and
body fat distribution, from childhood to adolescence that
may be responsible for the observed differences in the riskof higher %TF and IAF, in males and females, respectively,
in the development of NAFLD.
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